NUPR1 and familial pancreatic carcinoma: Congruently, using a comprehensive approach that combines biophysical, biochemical, computational, and biological methods for repurposing FDA approved drugs in the treatment of pancreatic cancer, we have recently identified that the phenothiazine derivative, trifluoperazine, mimics the effect of the genetic inactivation of NUPR1, revealing its anticancer properties20.